Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.48 EUR
357.60 M EUR
3.67 B EUR
40.53 M
About BIOMERIEUX
Sector
Industry
CEO
Pierre Boulud
Website
Headquarters
Marcy l'Etoile
Founded
1967
ISIN
FR0013280286
FIGI
BBG000QCJGB6
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. It develops testing, detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EYWN is 98.45 EUR — it has decreased by −3.00% in the past 24 hours. Watch BIOMERIEUX SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange BIOMERIEUX SA stocks are traded under the ticker EYWN.
EYWN stock has fallen by −1.94% compared to the previous week, the month change is a −7.21% fall, over the last year BIOMERIEUX SA has showed a 0.77% increase.
We've gathered analysts' opinions on BIOMERIEUX SA future price: according to them, EYWN price has a max estimate of 130.00 EUR and a min estimate of 91.00 EUR. Watch EYWN chart and read a more detailed BIOMERIEUX SA stock forecast: see what analysts think of BIOMERIEUX SA and suggest that you do with its stocks.
EYWN reached its all-time high on Sep 19, 2017 with the price of 207.02 EUR, and its all-time low was 53.90 EUR and was reached on Jan 4, 2019. View more price dynamics on EYWN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
EYWN stock is 3.10% volatile and has beta coefficient of 0.62. Track BIOMERIEUX SA stock price on the chart and check out the list of the most volatile stocks — is BIOMERIEUX SA there?
Today BIOMERIEUX SA has the market capitalization of 11.95 B, it has decreased by −0.58% over the last week.
Yes, you can track BIOMERIEUX SA financials in yearly and quarterly reports right on TradingView.
BIOMERIEUX SA is going to release the next earnings report on Mar 7, 2025. Keep track of upcoming events with our Earnings Calendar.
BIOMERIEUX SA revenue for the last half-year amounts to 1.90 B EUR, despite the estimated figure of 1.88 B EUR. In the next half-year revenue is expected to reach 1.88 B EUR.
EYWN net income for the last half-year is 215.30 M EUR, while the previous report showed 196.00 M EUR of net income which accounts for 9.85% change. Track more BIOMERIEUX SA financial stats to get the full picture.
Yes, EYWN dividends are paid annually. The last dividend per share was 0.85 EUR. As of today, Dividend Yield (TTM)% is 0.84%. Tracking BIOMERIEUX SA dividends might help you take more informed decisions.
BIOMERIEUX SA dividend yield was 0.84% in 2023, and payout ratio reached 28.08%. The year before the numbers were 0.87% and 22.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 15, 2024, the company has 14.65 K employees. See our rating of the largest employees — is BIOMERIEUX SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMERIEUX SA EBITDA is 825.80 M EUR, and current EBITDA margin is 21.64%. See more stats in BIOMERIEUX SA financial statements.
Like other stocks, EYWN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMERIEUX SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOMERIEUX SA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOMERIEUX SA stock shows the sell signal. See more of BIOMERIEUX SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.